MICHELLE WERNLE: Open Payments
NPI 1265160998 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,153 in 139 payments from 35 companies in 2025. Trend: 2023 $2,566 · 2024 $3,323 · 2025 $5,153
Food & beverage: $5,153
| Company | Payments | Amount |
|---|---|---|
| TG Therapeutics, Inc. | 11 | $945 |
| Axsome Therapeutics, Inc. | 11 | $457 |
| UCB, Inc. | 5 | $407 |
| Amgen Inc. | 4 | $396 |
| SK Life Science, Inc. | 5 | $340 |
| EMD Serono, Inc. | 3 | $336 |
| ABBVIE INC. | 21 | $281 |
| Teva Pharmaceuticals USA, Inc. | 16 | $260 |
| JAZZ PHARMACEUTICALS INC. | 5 | $227 |
| GENZYME CORPORATION | 3 | $216 |
Products named: BRIUMVI, Mavenclad, UPLIZNA, AUSTEDO XR, Fintepla, Symbravo, XYWAV, INGREZZA.
Industry payments across NY — which companies pay providers there.
